Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2003
11/05/2003EP1358883A1 Re-epithelializing pharmaceutical compositions containing xanthan gum
11/05/2003EP1358877A1 Compositions for oral use
11/05/2003EP1358353A2 Identification of genetic determinants of polymorphic cyp3a5 expression
11/05/2003EP1358325A2 Protein modification and maintenance molecules
11/05/2003EP1358323A2 Regulators of apoptosis
11/05/2003EP1358320A2 68730 and 69112 protein kinase molecules and uses therefor
11/05/2003EP1358212A1 Methods for the synthesis of a modified hemoglobin solution
11/05/2003EP1358209A2 Crystallization of igf-1
11/05/2003EP1358204A1 Tripeptide derivatives for the treatment of neurodegenerative diseases
11/05/2003EP1358203A2 Methods and compositions for use in spliceosome mediated rna trans-splicing
11/05/2003EP1358198A1 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
11/05/2003EP1358185A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003EP1358174A2 Inhibitors of cruzipain and other cysteine proteases
11/05/2003EP1358172A2 Amino ceramide-like compounds and therapeutic methods of use
11/05/2003EP1358171A2 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
11/05/2003EP1358165A1 Imidazole derivatives
11/05/2003EP1358162A1 Dihydroindole and tetrahydroquinoline derivatives
11/05/2003EP1358161A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
11/05/2003EP1358154A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/05/2003EP1357978A2 Hematopoietic stem cell gene therapy
11/05/2003EP1357977A2 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia
11/05/2003EP1357951A1 A medical dressing comprising an antimicrobial silver compound
11/05/2003EP1357944A2 Perylenequinones for use with immunotherapy agents
11/05/2003EP1357940A2 Hepatitis b virus treatment
11/05/2003EP1357938A2 Hyperblebbing bacterial strains and use thereof for production of vaccines
11/05/2003EP1357929A2 Modulation of immune response and methods based thereon
11/05/2003EP1357924A1 Antiviral composition made from medicinal plants for combating hiv/aids
11/05/2003EP1357921A2 Bacterial isolates from organisms that respire at least partially through their skin and biologically active extracts derived therefrom
11/05/2003EP1357920A2 Compositions and method of tissue superoxygenation
11/05/2003EP1357918A2 Metabolic controlled fermentation process for carbamoyl tobramycin production
11/05/2003EP1357917A2 Use of carbohydrates for eliminating intestinal infections in animals
11/05/2003EP1357909A1 Il-8 receptor antagonists
11/05/2003EP1357899A2 Oral itraconazole formulations and methods of making the same
11/05/2003EP1357895A2 Vaccine composition and stabilisation method
11/05/2003EP1357871A1 Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate
11/05/2003EP1220858B1 Oxazinoquinolones useful for the treatment of viral infections
11/05/2003EP1165494B1 Hsv primase inhibitors
11/05/2003EP1140113B1 Use of bisphosphonates for the prevention and treatment of infectious processes
11/05/2003EP1140058B1 N-formyl hydroxylamine derivatives as antibacterial agents
11/05/2003EP1135136B1 Pharmaceutical compositions containing olanzapine-n-oxide
11/05/2003EP1107973B1 NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/05/2003EP0973527B1 Extended release formulations of clarithromycin
11/05/2003EP0912194B1 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease
11/05/2003CN1454216A Antibodies to CCR5
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/05/2003CN1454213A Variants of allergenic proteins of the Group2 of dermatophagoides
11/05/2003CN1454212A Intermediates in cephalosporing production
11/05/2003CN1454204A IL-8 receptor antagonists
11/05/2003CN1454099A Dendrimer-photosensitizer complexes for medical applications
11/05/2003CN1454097A Polymer-modified synthetic proteins
11/05/2003CN1454093A Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections
11/05/2003CN1454091A Immunostimulatory nucleic acids
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1454082A Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
11/05/2003CN1453277A Meadowrueleaf corydalis general alkaloid and its prepn and application
11/05/2003CN1453035A Medicine for treating AlDS and its prepn
11/05/2003CN1453033A Freeze dried isatis root powder for injection and its prepn
11/05/2003CN1453030A Chinese medicine for preventing and treating SARS
11/05/2003CN1452984A Prepn of influenza-preventing antiserum
11/05/2003CN1452982A Mucosa administrated Ribavirin prepn for preventing & curing SARS and its prepn process
11/05/2003CN1452981A Herpes virus treating medicine composition and its production process
11/05/2003CN1452978A Application of citrus paradisi Micf seed in preparing medicine for resisting SARS virus
11/05/2003CN1452977A Clarithromycin injection
11/05/2003CN1452976A Compound glucose injection with clindamycin and metronidazole
11/05/2003CN1452975A Roxithromycin injection
11/05/2003CN1452974A Globeflower powder for injection and its prepn
11/05/2003CN1452968A Novel drug-fast bacteria resisting medicine composition and its prepn and use
11/05/2003CN1452967A Application of cepharanthine in preparing medicine for resisting SARS virus
11/05/2003CN1452963A Metronidazole prepn
11/05/2003CN1126754C Process for preparing 3-cephem compound
11/05/2003CN1126752C Neuraminic acid compounds
11/05/2003CN1126569C Low pathogenicity PRRS live virus vaccines and methods of preparation thereof
11/05/2003CN1126568C Adjuvant used in vaccine
11/04/2003US6642391 Amycolatopsis culture product; antibiotic
11/04/2003US6642371 Haemophilus adherence and penetration proteins
11/04/2003US6642367 Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom
11/04/2003US6642365 Anti-(retro)viral conjugates of saccharides and acetamidino or guanidino compounds
11/04/2003US6642359 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease
11/04/2003US6642354 Molecular mimetics of unique Neisseria meningitidis serogroup B epitopes
11/04/2003US6642276 Controlled release macrolide pharmaceutical formulations
11/04/2003US6642271 Potentiating compounds
11/04/2003US6642270 7-substituted fused ring tetracycline compounds
11/04/2003US6642267 Side effect reduction over opioid analgesics; analgesic and/or anxiolytic action
11/04/2003US6642258 Use of central cannabinoid receptor antagonist for preparing medicines
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642237 Inhibitors of HIV protease and inhibitors of HIV replication, used in the prevention or treatment of infection by HIV and treatment for AIDS
11/04/2003US6642227 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
11/04/2003US6642217 Triterpenes having human antifungal and antiyeast activity
11/04/2003US6642206 Monocyclic L-nucleosides, analogs and uses thereof
11/04/2003US6642203 Purified peptide from penaeid prawns, having specified molecular mass and isoelectric pH, comprising proline-rich N-terminal region and C-terminal region having 6 cysteine residues forming three intramolecular disulfide bridges
11/04/2003US6642201 Use of a dipeptide for stimulating repair processes
11/04/2003US6642023 High molecular weight; encoded by isolated nucleic acid; expression vectors; use for diagnostics, prophylaxis and treatment of infections
11/04/2003US6642017 Modulating production of pneumococcal capsular polysaccharide
11/04/2003US6642008 Assays and therapies for latent viral infection
11/04/2003US6641843 Pharmaceutical compositions
11/04/2003US6641819 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142
11/04/2003US6641817 Herpes virus vectors for dendritic cells
11/04/2003US6641816 Use of poxviruses as enhancer of specific immunity